MyAverix Finance
SHG · Healthcare
Heilongjiang ZBD Pharmaceutical Co Ltd (603567)
Drug Manufacturers - Specialty & Generic
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $6.62B, P/E ratio is 18.00, net margin is -20.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603567
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — FAQ
What is Heilongjiang ZBD Pharmaceutical Co Ltd's market cap?
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a reported market cap of $6.62B (data as of 2026-03-29).
What is 603567's P/E ratio?
The price-to-earnings (P/E) ratio for Heilongjiang ZBD Pharmaceutical Co Ltd (603567) is 18.00 (data as of 2026-03-29).
Does Heilongjiang ZBD Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Heilongjiang ZBD Pharmaceutical Co Ltd (603567). Check the MyAverix Finance app for the latest dividend data.
What sector is Heilongjiang ZBD Pharmaceutical Co Ltd in?
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603567 listed on?
603567 is listed on SHG.
What is Heilongjiang ZBD Pharmaceutical Co Ltd's net margin?
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) reports a net margin of -20.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.